218 related articles for article (PubMed ID: 26203081)
21. Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol.
Toran-Allerand CD
Ann N Y Acad Sci; 2005 Jun; 1052():136-44. PubMed ID: 16024756
[TBL] [Abstract][Full Text] [Related]
22. Estrogen and cerebrovascular regulation in menopause.
Raz L
Mol Cell Endocrinol; 2014 May; 389(1-2):22-30. PubMed ID: 24472522
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptors and ischemic neuroprotection: who, what, where, and when?
Schreihofer DA; Ma Y
Brain Res; 2013 Jun; 1514():107-22. PubMed ID: 23500634
[TBL] [Abstract][Full Text] [Related]
24. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology.
Simpkins JW; Wen Y; Perez E; Yang S; Wang X
Ann N Y Acad Sci; 2005 Jun; 1052():233-42. PubMed ID: 16024766
[TBL] [Abstract][Full Text] [Related]
25. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
[TBL] [Abstract][Full Text] [Related]
26. Genistein selectively inhibits estrogen-induced cell proliferation and other responses to hormone stimulation in the prepubertal rat uterus.
Gaete L; Tchernitchin AN; Bustamante R; Villena J; Lemus I; Gidekel M; Cabrera G; Carrillo O
J Med Food; 2011 Dec; 14(12):1597-603. PubMed ID: 21612459
[TBL] [Abstract][Full Text] [Related]
27. 17alpha-estradiol: a brain-active estrogen?
Toran-Allerand CD; Tinnikov AA; Singh RJ; Nethrapalli IS
Endocrinology; 2005 Sep; 146(9):3843-50. PubMed ID: 15947006
[TBL] [Abstract][Full Text] [Related]
28. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice.
Cai M; Ma YL; Qin P; Li Y; Zhang LX; Nie H; Peng Z; Dong H; Dong HL; Hou WG; Xiong LZ
Neurosci Lett; 2014 Jan; 558():115-9. PubMed ID: 24246902
[TBL] [Abstract][Full Text] [Related]
29. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
30. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
32. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
33. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
34. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
35. Nonoral routes of estrogen administration.
Cedars MI; Judd HL
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):269-98. PubMed ID: 3306522
[TBL] [Abstract][Full Text] [Related]
36. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
37. Evidence to implicate early modulation of interleukin-1beta expression in the neuroprotection afforded by 17beta-estradiol in male rats undergone transient middle cerebral artery occlusion.
Chiappetta O; Gliozzi M; Siviglia E; Amantea D; Morrone LA; Berliocchi L; Bagetta G; Corasaniti MT
Int Rev Neurobiol; 2007; 82():357-72. PubMed ID: 17678971
[TBL] [Abstract][Full Text] [Related]
38. 17beta-estradiol and enriched environment accelerate cognitive recovery after focal brain ischemia.
Söderström I; Strand M; Ingridsson AC; Nasic S; Olsson T
Eur J Neurosci; 2009 Mar; 29(6):1215-24. PubMed ID: 19302156
[TBL] [Abstract][Full Text] [Related]
39. Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
Liu ZJ; Lee WJ; Zhu BT
Cancer Res; 2005 Jul; 65(13):5802-11. PubMed ID: 15994956
[TBL] [Abstract][Full Text] [Related]
40. Novel ligands balance estrogen receptor β and α agonism for safe and effective suppression of the vasomotor response in the ovariectomized female rat model of menopause.
McGregor C; Sau A; Ruddy SC; Leung D; Webb M; Durst T; Wright JS; Lagace D; Pratt MA
Endocrinology; 2014 Jul; 155(7):2480-91. PubMed ID: 24823389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
